Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cashflow Statement

NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax₹862 Cr₹202 Cr₹580 Cr₹569 Cr₹825 Cr
Adjustment ₹102 Cr₹124 Cr₹62 Cr₹54 Cr₹14 Cr
Changes In working Capital ₹63 Cr₹-231 Cr₹-213 Cr₹-98 Cr₹8.60 Cr
Cash Flow after changes in Working Capital ₹1,027 Cr₹95 Cr₹429 Cr₹525 Cr₹848 Cr
Cash Flow from Operating Activities ₹849 Cr₹47 Cr₹299 Cr₹417 Cr₹669 Cr
Cash Flow from Investing Activities ₹-477 Cr₹-5.30 Cr₹-103 Cr₹-167 Cr₹-612 Cr
Cash Flow from Financing Activities ₹-363 Cr₹35 Cr₹-186 Cr₹-251 Cr₹-51 Cr
Net Cash Inflow / Outflow ₹9.00 Cr₹76 Cr₹9.80 Cr₹-0.50 Cr₹5.70 Cr
Opening Cash & Cash Equivalents ₹111 Cr₹26 Cr₹20 Cr₹28 Cr₹22 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹12 Cr₹9.30 Cr₹-3.80 Cr₹-8.00 Cr₹0.90 Cr
Closing Cash & Cash Equivalent ₹132 Cr₹111 Cr₹26 Cr₹20 Cr₹28 Cr

Compare Cashflow Statement of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹18,304.9 Cr 2.4% 7.2% 75.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹364,831.0 Cr -0.1% -2.8% 50.3% Stock Analytics
CIPLA ₹113,471.0 Cr 4.5% -3.1% 52.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,713.0 Cr 4.6% 1.4% 22.2% Stock Analytics
DIVIS LABORATORIES ₹101,960.0 Cr 4.7% 10.8% 18.1% Stock Analytics
ZYDUS LIFESCIENCES ₹95,687.8 Cr 3.1% -4.1% 80.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

2.4%

7.2%

75.7%

SENSEX

1.3%

2.6%

24%


You may also like the below Video Courses